Kuru Satoshi
Department of Neurology, National Hospital Organization Suzuka Hospital.
Rinsho Shinkeigaku. 2021 Feb 23;61(2):109-114. doi: 10.5692/clinicalneurol.cn-001500. Epub 2021 Jan 26.
SMON (subacute myelo-optico-neuropathy) is toxic neurological disease which had a profound impact on the population in Japan in 1960's. The clinical characteristics of SMON includes an ascending sensory disturbance, spasticity, and visual impairment typically following abdominal symptoms. Infection was first suspected as an underlying cause of this epidemic. The disorder was ultimately attributed to the overuse of clioquinol, based on the analysis of green urine from affected patients and confirmed by the epidemiological surveys and experimental animal studies. The factors that contributed to the prevalence of SMON which remains the worst example of drug-associated toxicity in Japan to date include the conversion of clioquinol from a purely topical agent to an orally-administered drug, dogma associated with drug safety, relatively limited regulation of drug use, an increase in the number of prescriptions due to the availability of universal insurance, as well as the complexity of the associated abdominal symptoms. Periodical examination of the patients diagnosed with SMON continues to this day. As such, it is important to have a better understanding of clioquinol-induced neurotoxicity together with the mechanisms underlying drug susceptibility; we should not permit the memory of this severe and prominent drug-associated toxicity fade from view.
亚急性脊髓视神经病(SMON)是一种中毒性神经疾病,在20世纪60年代对日本民众产生了深远影响。SMON的临床特征包括上行性感觉障碍、痉挛,以及通常在腹部症状之后出现的视力损害。最初怀疑感染是这场流行病的潜在病因。基于对患病患者绿色尿液的分析,该疾病最终归因于氯碘羟喹的过度使用,并通过流行病学调查和实验动物研究得到证实。导致SMON流行的因素,至今仍是日本药物相关毒性最严重的例子,包括氯碘羟喹从单纯的局部用药转变为口服药物、与药物安全性相关的教条、药物使用监管相对有限、全民保险导致处方数量增加,以及相关腹部症状的复杂性。对被诊断为SMON的患者的定期检查一直持续至今。因此,更深入了解氯碘羟喹诱导的神经毒性以及药物易感性的潜在机制非常重要;我们不应让这种严重且突出的药物相关毒性的记忆从视野中消失。